About Aurelia bioscience ltd
Aurelia Bioscience Ltd: A Leading Contract Research Organization in the UK
Aurelia Bioscience Ltd is a renowned contract research organization (CRO) based in the United Kingdom. The company has been providing high-quality research services to pharmaceutical and biotechnology companies for over a decade. Aurelia Bioscience Ltd is committed to delivering innovative solutions that help its clients accelerate their drug discovery and development programs.
The company's success can be attributed to its team of highly skilled scientists who have extensive experience in drug discovery, medicinal chemistry, and pharmacology. Aurelia Bioscience Ltd's scientists work closely with clients to understand their specific needs and develop customized solutions that meet their requirements.
Aurelia Bioscience Ltd offers a wide range of services, including assay development, hit identification, lead optimization, pharmacokinetics studies, toxicology studies, and more. The company uses state-of-the-art equipment and technologies to ensure accurate results and timely delivery of projects.
One of the key strengths of Aurelia Bioscience Ltd is its expertise in fragment-based drug discovery (FBDD). FBDD is an innovative approach that involves screening small molecules against protein targets using techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy. This approach has proven highly successful in identifying novel drug candidates with high potency and selectivity.
Aurelia Bioscience Ltd has also developed proprietary technologies such as "FragScreen" which enables rapid screening of large compound libraries against protein targets using NMR spectroscopy. This technology allows for efficient hit identification while minimizing false positives.
In addition to its scientific expertise, Aurelia Bioscience Ltd places great emphasis on quality assurance. The company operates under strict regulatory guidelines such as Good Laboratory Practice (GLP) ensuring that all data generated by the company meets international standards for accuracy and reliability.
Aurelia Bioscience Ltd has received numerous awards for its outstanding contributions to the pharmaceutical and biotechnology industries. In 2019, the company was awarded "CRO of the Year" at the prestigious PharmaTimes Awards.
In conclusion, Aurelia Bioscience Ltd is a leading CRO in the UK with a proven track record of delivering high-quality research services to its clients. The company's expertise in FBDD and proprietary technologies such as FragScreen make it an ideal partner for drug discovery and development programs. With its commitment to quality assurance and regulatory compliance, Aurelia Bioscience Ltd is well-positioned to continue its success in the years ahead.